Insider Transactions last 24 months for Cullinan Therapeutics, Inc.  -  NSDQ: CGEM

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Michaelson JenniferChief Scientific Officer03/05/2026DSDirectCOM8,000$15.68$125,440.00170,844
Michaelson JenniferChief Scientific Officer03/05/2026AMDirectCOM4,000$4.30$17,200.00178,844
Michaelson JenniferChief Scientific Officer02/25/2026DSDirectCOM1,780$14.14$25,169.20174,844
Sumer Jacquelyn LChief Legal Officer02/24/2026DSDirectCOM3,601$14.47$52,106.47128,089
Jones Jeffrey AlanChief Medical Officer02/24/2026DSDirectCOM4,582$14.47$66,301.54159,968
Ahmed NadimPresident and CEO02/24/2026DSDirectCOM13,515$14.47$195,562.05390,803
Michaelson JenniferChief Scientific Officer02/24/2026DSDirectCOM3,601$14.47$52,106.47176,624
Michaelson JenniferChief Scientific Officer02/23/2026DSDirectCOM1,752$13.99$24,510.48180,225
Ahmed NadimPresident and CEO02/20/2026DSDirectCOM16,381$13.62$223,109.22404,318
Sumer Jacquelyn LChief Legal Officer02/20/2026DSDirectCOM3,742$13.62$50,966.04131,690
Michaelson JenniferChief Scientific Officer02/20/2026DSDirectCOM8,000$14.30$114,400.00181,977
Michaelson JenniferChief Scientific Officer02/20/2026AMDirectCOM8,000$4.30$34,400.00189,977
Michaelson JenniferChief Scientific Officer02/20/2026DSDirectCOM3,742$13.62$50,966.04181,977
Jones Jeffrey AlanChief Medical Officer02/20/2026DSDirectCOM4,982$13.62$67,854.84164,550
Fenton Mary KayChief Financial Officer02/20/2026DSDirectCOM4,398$13.62$59,900.76126,380
Michaelson JenniferChief Scientific Officer02/18/2026AADirectCOM57,500$0.00$0.00185,719
Fenton Mary KayChief Financial Officer02/18/2026AADirectCOM68,750$0.00$0.00130,778
Michaelson JenniferChief Scientific Officer02/12/2026DSDirectCOM416$12.03$5,004.48128,219
Michaelson JenniferChief Scientific Officer01/22/2026DSDirectCOM4,000$12.30$49,200.00128,635
Fenton Mary KayChief Financial Officer12/31/2025AADirectCOM27$6.49$175.2362,028
Ahmed NadimPresident and CEO12/23/2025DSDirectCOM9,922$10.01$99,319.22420,699
Michaelson JenniferChief Scientific Officer12/19/2025DSDirectCOM1,345$10.01$13,463.45132,635
Michaelson JenniferChief Scientific Officer12/18/2025DSDirectCOM2,898$9.67$28,023.66133,980
Jones Jeffrey AlanChief Medical Officer12/18/2025DSDirectCOM4,632$9.67$44,791.44169,532
Sumer Jacquelyn LChief Legal Officer12/18/2025DSDirectCOM3,480$9.67$33,651.60135,432
1   2  3  Next Last  You are at page 1 of 3 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel